NGBiLab S3.E11: Vasomune Therapeutics
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
NGBiLab S3.E11: Vasomune Therapeutics
-
Narrated by:
-
By:
Summary
Vasomune Therapeutics is a clinical stage biotech company that spun out of Sunnybrook Research Institute in Toronto. Their lead molecule targets vascular leak, a common underlying factor in some of the most serious conditions in medicine including sepsis, pneumonia, cerebral edema, and severe burns.
In this episode, Jim Wilson speaks with the President and CEO if Vasomune, Brian Jahns, about a company that has made remarkable progress to date and secures nearly $10million USD in non-dilutive funding.
Brian makes a passionate case for Canadian self-reliance in life sciences... and asks Jim to share how the NGBi podcasts started.
adbl_web_anon_alc_button_suppression_c
No reviews yet